Bayer Stock Analysis - Turnaround with Nuance
Bayer faces thousands of claims that its weed-killer causes cancer and the U.S. Supreme Court agreed to review the litigation. That decision together with earnings preceded a 70% rally. The company reports in euros and has major agriculture and pharmaceut ...